Table 2.
Stimulation and clinical outcomes
| Controls n = 24 |
Intervention n = 19 |
W/Χ2* | p value | Total n = 43 |
|
|---|---|---|---|---|---|
| Total FSH | 2250 (337.5) | 1650 (325) | 402 | 0.00002 | 1975 (587.5) |
| Days to hCG | 11 (2) | 11 (2.5) | 193.5 | 0.3944 | 11 (2) |
| PEAK E2 | 2089.5 (1060.5) | 2546 (1002) | 181 | 0.2554 | 2416 (1058) |
| Oocytes | 12.5 (7.5) | 15 (7.5) | 247 | 0.6492 | 14 (7) |
| MII oocytes | 11 (6) | 10 (5) | 278.5 | 0.2193 | 10 (5.5) |
| MII rate | 0.8 (0.117) | 0.76 (0.14) | 298.5 | 0.08646 | 0.77 (0.11) |
| 2PN | 9 (3.75) | 9 (2.5) | 268 | 0.3286 | 9 (3) |
| Fertilization rate | 0.82 (0.155) | 0.81 (0.165) | 228.5 | 1 | 0.82 (0.17) |
| D5 blastocyst | 3.5 (2) | 4 (2) | 164.5 | 0.1164 | 4 (3) |
| Blastocyst rate | 0.32 (0.165) | 0.55 (0.205) | 92 | 0.0009 | 0.4 (0.25) |
| Implantation rate | 32% | 64% | 3.5192* | 0.0606 | 47% |
| Clinical pregnancy rate | 33% | 58% | 1.6937* | 0. 1931 | 44% |
| Follicular Hcy | 24.34 (22.85) | 7.62 (13.19) | 241 | 0.6208 | 10.61 (18.23) |
Continuous data are presented as median (IQR) and analyzed by Wilcoxon rank sum test (W). Categorical data (pregnancy rates) are summarized by absolute frequencies and analyzed by chi-square tests with Yates’ correction (Χ2*)